Immix Biopharma, Inc.
IMMX
$8.18
$0.172.12%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 100.41M | 15.95M | 11.64M | 15.92M | 17.68M |
| Total Receivables | -- | -- | -- | -- | 1.97M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 677.60K | 504.20K | 549.80K | 689.70K | 509.20K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 150.70K | 132.80K | 137.70K | 168.40K | 32.30K |
| Total Current Assets | 101.24M | 16.58M | 12.33M | 16.78M | 20.20M |
|
|
|||||
| Total Current Assets | 101.24M | 16.58M | 12.33M | 16.78M | 20.20M |
| Net Property, Plant & Equipment | 3.49M | 3.36M | 3.18M | 3.09M | 2.73M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 114.00K | 132.10K | 131.00K | 20.40K | 20.40K |
| Total Assets | 104.84M | 20.08M | 15.64M | 19.89M | 22.95M |
|
|
|||||
| Total Accounts Payable | 5.44M | 7.05M | 6.61M | 5.74M | 5.39M |
| Total Accrued Expenses | 4.53M | 3.66M | 3.32M | 3.50M | 3.23M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 139.30K | 141.30K | 70.50K | 67.80K | 65.20K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 10.11M | 10.85M | 10.01M | 9.31M | 8.69M |
|
|
|||||
| Total Current Liabilities | 10.11M | 10.85M | 10.01M | 9.31M | 8.69M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 933.60K | 965.10K | 972.30K | 991.10K | 1.01M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 11.04M | 11.82M | 10.98M | 10.30M | 9.70M |
|
|
|||||
| Common Stock & APIC | 198.30M | 102.08M | 90.88M | 89.25M | 88.38M |
| Retained Earnings | -104.46M | -93.78M | -86.19M | -79.57M | -75.02M |
| Treasury Stock & Other | -39.80K | -37.50K | -34.90K | -84.50K | -101.00K |
| Total Common Equity | 93.80M | 8.27M | 4.65M | 9.59M | 13.25M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 93.80M | 8.27M | 4.65M | 9.59M | 13.25M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 93.80M | 8.27M | 4.65M | 9.59M | 13.25M |
|
|
|||||